FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386891820> ?p ?o ?g. }

• W4386891820 abstract "Background: It is an important clinical means to identify benign and malignant breast diseases caused by nipple discharge through the detection and analysis of components in nipple discharge. This study was aimed to test the expression and clinical significance of carbohydrate antigen 125 (CA125), carbohydrate antigen 153 (CA153) and carcinoembryonic antigen (CEA) in nipple discharge of breast cancer patients. &#x0D; Methods: From January 2017 to December 2018, 86 patients with invasive ductal carcinoma of the breast with nipple discharge (breast cancer group) and 50 patients with ordinary breast duct hyperplasia with nipple discharge (benign control group) were selected, and the nipple discharge and serum CA125, CA153 and CEA levels in the two groups were detected by electrochemiluminescence immunoassay.&#x0D; Results: The nipple discharge and serum CA125, CA153 and CEA levels in the benign control group were significantly lower than those in the breast cancer group, and the serum CA125, CA153 and CEA levels were obviously lower than those nipple discharge levels. The expression levels of CA125, CA153 and CEA in nipple discharge in the breast cancer group had no significant difference in different age of onset and different tumor sites. The CA125, CA153 and CEA levels in nipple discharge of patients with tumor diameter n5 cm, low differentiation, high stage, metastasis, and recurrence were obviously elevated versus to those of patients with tumor diameter <5 cm, high differentiation, low stage, and no metastasis and recurrence. These levels were not significantly correlated with the expression of estrogen receptor (ER) and progesterone receptor (PR), but was significantly correlated with the expression of human epidermal growth factor receptor (HER-2) and Ki-67. The accuracy, sensitivity, and negative predictive value of nipple discharge CA125, CA153 and CEA combined tests in the diagnosis of breast cancer were markedly improved compared with serum combinations and individual tests.&#x0D; Conclusion: The combination of CA125, CA153 and CEA in nipple discharge can be considered as a potential diagnostic method for breast cancer, which is an effective supplement to serological diagnosis, and can provide new ideas for the differential diagnosis of benign and malignant breast cancer with nipple discharge." @default.
• W4386891820 created "2023-09-21" @default.
• W4386891820 creator A5003875185 @default.
• W4386891820 creator A5048286287 @default.
• W4386891820 creator A5060869220 @default.
• W4386891820 creator A5061269246 @default.
• W4386891820 creator A5074461924 @default.
• W4386891820 creator A5083013613 @default.
• W4386891820 date "2023-09-20" @default.
• W4386891820 modified "2023-09-27" @default.
• W4386891820 title "Expression and clinical significance of CA125, CA153 and CEA in nipple discharge of breast cancer patients" @default.
• W4386891820 doi "https://doi.org/10.5937/jomb0-45192" @default.
• W4386891820 hasPublicationYear "2023" @default.
• W4386891820 type Work @default.
• W4386891820 citedByCount "0" @default.
• W4386891820 crossrefType "journal-article" @default.
• W4386891820 hasAuthorship W4386891820A5003875185 @default.
• W4386891820 hasAuthorship W4386891820A5048286287 @default.
• W4386891820 hasAuthorship W4386891820A5060869220 @default.
• W4386891820 hasAuthorship W4386891820A5061269246 @default.
• W4386891820 hasAuthorship W4386891820A5074461924 @default.
• W4386891820 hasAuthorship W4386891820A5083013613 @default.
• W4386891820 hasBestOaLocation W43868918201 @default.
• W4386891820 hasConcept C121608353 @default.
• W4386891820 hasConcept C126322002 @default.
• W4386891820 hasConcept C143998085 @default.
• W4386891820 hasConcept C2777387746 @default.
• W4386891820 hasConcept C2779013556 @default.
• W4386891820 hasConcept C2780472235 @default.
• W4386891820 hasConcept C2780898380 @default.
• W4386891820 hasConcept C530470458 @default.
• W4386891820 hasConcept C63363279 @default.
• W4386891820 hasConcept C71924100 @default.
• W4386891820 hasConcept C90924648 @default.
• W4386891820 hasConceptScore W4386891820C121608353 @default.
• W4386891820 hasConceptScore W4386891820C126322002 @default.
• W4386891820 hasConceptScore W4386891820C143998085 @default.
• W4386891820 hasConceptScore W4386891820C2777387746 @default.
• W4386891820 hasConceptScore W4386891820C2779013556 @default.
• W4386891820 hasConceptScore W4386891820C2780472235 @default.
• W4386891820 hasConceptScore W4386891820C2780898380 @default.
• W4386891820 hasConceptScore W4386891820C530470458 @default.
• W4386891820 hasConceptScore W4386891820C63363279 @default.
• W4386891820 hasConceptScore W4386891820C71924100 @default.
• W4386891820 hasConceptScore W4386891820C90924648 @default.
• W4386891820 hasLocation W43868918201 @default.
• W4386891820 hasOpenAccess W4386891820 @default.
• W4386891820 hasPrimaryLocation W43868918201 @default.
• W4386891820 hasRelatedWork W150871787 @default.
• W4386891820 hasRelatedWork W2035626907 @default.
• W4386891820 hasRelatedWork W2074067093 @default.
• W4386891820 hasRelatedWork W2224319365 @default.
• W4386891820 hasRelatedWork W2262938662 @default.
• W4386891820 hasRelatedWork W2354400911 @default.
• W4386891820 hasRelatedWork W2371316149 @default.
• W4386891820 hasRelatedWork W2384739398 @default.
• W4386891820 hasRelatedWork W2400938991 @default.
• W4386891820 hasRelatedWork W2897588803 @default.
• W4386891820 isParatext "false" @default.
• W4386891820 isRetracted "false" @default.
• W4386891820 workType "article" @default.